Andrew Gengos
Tracked across 1 events · 6 articles · First seen Jun 15, 2026 · Last active Jun 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Andrew Gengos was appointed Chief Financial Officer of Immuneering, bringing over 25 years of leadership experience in biotech to oversee financial strategy, capital allocation, investor relations, business development, and corporate development activities.
Jun 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Andrew Gengos live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard